Report of Objective Responses of Glioma Patients to Pharmaceutical Grade Synthetic Cannabidiol


This is an observational study of objective responses of Glioma patients to Pharmaceutical Grade Synthetic Cannabidiol. 14 assessable cases were identified, 9 showed a clinical response, 5 showed no effect.

Click here for full text (external link)

Leave a Reply

Your email address will not be published. Required fields are marked *

Social media & sharing icons powered by UltimatelySocial